Todd C. Davis is Director at LIGAND PHARMACEUTICALS INC (LGND). They have made 14 open-market trades across 4 companies since 2011, most recently 2026-06-11.
CIK 0001392029
6 open-market purchases totalling $3.7M since 2011, against 8 sales. Across 6 scored buys the stock is up 12.7% at ninety days, and 6.2 points ahead of the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| LGND | 199,381 | $58.9M |
| PTHS | 75,834 | $1.5M |
| BDSI | 252,207 | $1.4M |
| VXRT | 125,905 | $41K |
| CHRO | 29,167 | $39K |
| Total | $62.0M |
Shares reported on the most recent Form 4, priced at the 2026-06-15 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 50% | 17% | 67% |
| Avg Move | -2.4% | -3.2% | +12.7% |
| Alpha | -1.2% | -4.2% | +6.2% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PTHS | BUY | 2026-06-11 | 2026-06-15 | $27.82 | $1000K | +2.3% | -1.3% | -23.4% |
| LGND | BUY | 2025-05-09 | 2025-05-13 | $105.20 | $2.0M | -5.5% | +6.5% | +36.7% |
| LGND | BUY | 2024-08-08 | 2024-08-09 | $97.39 | $243K | +2.7% | -0.5% | +25.8% |
| LGND | BUY | 2023-09-22 | 2023-09-25 | $59.38 | $238K | -4.1% | -17.0% | +19.9% |
| LGND | SELL | 2021-02-10 | 2021-02-12 | $213.14 | $2.2M | -16.7% | -9.4% | -31.3% |
| BDSI | SELL | 2020-08-18 | 2020-08-20 | $4.99 | $250K | -23.6% | -21.8% | -19.8% |
| VXRT | SELL | 2020-04-28 | 2020-04-30 | $3.28 | $197K | +2.8% | -2.5% | +251.6% |
| BDSI | SELL | 2019-11-15 | 2019-11-19 | $6.11 | $1.2M | +13.1% | +5.9% | -13.1% |
| LGND | BUY | 2019-08-02 | 2019-08-05 | $93.59 | $94K | +0.3% | -3.8% | +20.6% |
| LGND | SELL | 2018-10-08 | 2018-10-09 | $253.99 | $635K | -19.8% | -26.8% | -39.0% |
| LGND | SELL | 2018-08-16 | 2018-08-17 | $239.78 | $4.3M | +3.4% | +2.2% | -38.8% |
| LGND | SELL | 2018-02-26 | 2018-02-27 | $152.37 | $5.2M | +16.1% | +9.0% | +23.4% |
| LGND | SELL | 2014-03-18 | 2014-03-20 | $79.57 | $597K | -9.9% | -3.4% | -3.4% |
| LGND | BUY | 2011-08-10 | 2011-08-11 | $10.90 | $164K | -9.9% | -3.4% | -3.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.